Decheng Capital Global Life Sciences Fund IV, L.P.

Insider Reports History

Location
Grand Cayman, Cayman Islands
Signature
Decheng Capital Global Life Sciences Fund IV, L.P., By Decheng Capital Management IV (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Decheng Capital Global Life Sciences Fund IV, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
CG Oncology, Inc. 10%+ Owner Common Stock 4,958,810 $175,343,522 $35.36 29 Jan 2024 Direct
Aardvark Therapeutics, Inc. 10%+ Owner Common Stock 2,958,887 14 Feb 2025 By Decheng Capital Global Life Sciences Fund IV, L.P.
Aardvark Therapeutics, Inc. 10%+ Owner Common Stock 958,412 14 Feb 2025 By Decheng Capital Global Healthcare Fund (Master), LP
Aardvark Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 14 Feb 2025 By Decheng Capital Global Healthcare Fund (Master), LP
Aardvark Therapeutics, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 14 Feb 2025 By Decheng Capital Global Life Sciences Fund IV, L.P.
CG Oncology, Inc. 10%+ Owner Series C Preferred Stock 0 29 Jan 2024 Direct
CG Oncology, Inc. 10%+ Owner Series E Preferred Stock 0 29 Jan 2024 Direct
CG Oncology, Inc. 10%+ Owner Series F Preferred Stock 0 29 Jan 2024 Direct

Insider Reports Filed by Decheng Capital Global Life Sciences Fund IV, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AARD Aardvark Therapeutics, Inc. 14 Feb 2025 6 +$20,000,000 4 10%+ Owner 19 Feb 2025, 17:44
AARD Aardvark Therapeutics, Inc. 12 Feb 2025 0 $0 3 10%+ Owner 12 Feb 2025, 19:47
CGON CG Oncology, Inc. 29 Jan 2024 1 +$7,600,000 4/A 10%+ Owner 09 Apr 2024, 19:08
CGON CG Oncology, Inc. 29 Jan 2024 5 +$7,600,000 4 10%+ Owner 31 Jan 2024, 16:17
CGON CG Oncology, Inc. 24 Jan 2024 0 $0 3 10%+ Owner 24 Jan 2024, 20:26